Timing of changing therapy from gemcitabine and cisplatin chemotherapy based on real-world data of advanced urothelial carcinoma

Cisplatin-based systemic chemotherapy is the gold-standard approach for the first-line treatment of patients with advanced or metastatic urothelial carcinoma (UC). However, the optimal number of cycles is still unclear. The current study retrospectively assessed the clinical outcome in patients who...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Oncol Lett
Main Authors: Furubayashi, Nobuki, Negishi, Takahito, Takamatsu, Dai, Ieiri, Kosuke, Inoue, Tomohiro, Tsukino, Keiji, Nakamura, Motonobu
Formato: Artigo
Idioma:Inglês
Publicado em: D.A. Spandidos 2020
Assuntos:
Articles
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7074169/
https://ncbi.nlm.nih.gov/pubmed/32256805
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/ol.2020.11368
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados